Background
Methods
Eligibility criteria
Search strategy and record screen
Pubmed: | Embase: | Web of science: | Cochrane library: |
---|---|---|---|
((((“Periodontal Diseases”[Mesh] OR “Periodontitis”[Mesh]) OR “Dental Scaling”[Mesh]) OR “Periodontics”[Mesh]) OR (((((((periodontal disease[Title/Abstract] OR periodontitis[Title/Abstract]) OR periodontal pocket[Title/Abstract]) OR periodontal tissue[Title/Abstract]) OR periodontal therapy[Title/Abstract]) OR periodontal treatment[Title/Abstract]) OR scaling and root planning[Title/Abstract]) OR SRP[Title/Abstract]) AND ((((leptin[Title/Abstract] OR adiponectin[Title/Abstract]) OR adipokine[Title/Abstract]) OR adipocytokine[Title/Abstract]) OR ((“Adipokines”[Mesh] OR “Leptin”[Mesh]) OR “Adiponectin”[Mesh])) | ‘periodontal disease’/exp OR ‘periodontitis’/exp OR ‘periodontics’/exp OR ‘periodontal disease’:ab,ti OR ‘periodontitis’:ab,ti OR ‘periodontal pocket’:ab,ti OR ‘periodontal tissue’:ab,ti OR ‘periodontal therapy’:ab,ti OR ‘periodontal treatment’:ab,ti OR ‘scaling and root planning’:ab,ti OR ‘srp’:ab,ti AND (‘leptin’/exp OR ‘adiponectin’/exp OR ‘adipocytokine’/exp OR ‘leptin’:ab,ti OR ‘adiponectin’:ab,ti OR ‘adipokine’:ab,ti OR ‘adipocytokine’:ab,ti) | #1:TS = (periodontal disease) OR TS = (periodontitis) OR TS = (periodontal treatment) OR TS = (periodontal therapy) OR TS = (SRP) OR TS = (scaling and root planning) OR TS = (periodontal pocket) OR TS = (periodontal tissue) #2:TS = (adipokine) OR TS = (adipocytokine) OR TS = (leptin)OR TS = (adiponectin) #1 AND #2 | #1: “periodontal disease”:ti,ab,kw; #2:“periodontitis”:ti,ab,kw; #3: periodontal treatment:ti,ab,kw; #4: periodontal therapy:ti,ab,kw; #5: scaling and root planning:ti,ab,kw; #6: SRP:ti,ab,kw; #7: “periodontal pocket”:ti,ab,kw; #8: periodontal tissue:ti,ab,kw; #9: #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8; #10:“adipokine”:ti,ab,kw; #11: “adipocytokine”:ti,ab,kw; #12: “leptin”:ti,ab,kw; #13:“adiponectin”:ti,ab,kw; #14: #10 or #11 or #12 or #13; #15 :#9 and #14 |
Data extraction
Quality assessment
Data Analyses
Results
Study selection
Characteristics and quality assessment
Authors and years | Study design | Country (Ethnicity) | Type of periodontitis | Group size (PG/HG) | Age(PG/HG) | BMI(PG/HG) | Systemic disease | Smoking | Adipokine | Quality assessment | |
---|---|---|---|---|---|---|---|---|---|---|---|
Ay, Z. Y. 2012 | Cross-sectional | Turkey (Caucasion) | CP/AP | 21/20 | 47/37/33 | 28/27.6/24.39 | Free | Free | Leptin | ●●●○●●●○○○○(6/12) | |
Ay, Z. Y 2013 | Cross-sectional | Turkey (Caucasion) | AP | 6/6 | 38.67/32.33 | 25.78/23.20 | Free | Free | Leptin | ●●●○●●●●○○○(7/12) | |
Cecilia C Z 2015 | Cross-sectional | Sweden (Caucasion) | P | 14/61 | 14.5/14.5 | 35.9/37.4 | Not mentioned | Mixed | Leptin/Adiponectin | ●●●○●●●●○○○(7/12) | |
Davies, R. C. 2011 | Cross-sectional | UK (Caucasion) | AP | 30/30 | 36.7/36.3 | 26.0/25.3 | Free | Mixed | Leptin/Adiponectin | ●●○○●●●●○○○(6/12) | |
Furugen, R 2008 | Cross-sectional | Japan(Asian) | CP | 84/70 | 76/76 | 22.77/22.39 | Not mentioned | Mixed | Adiponectin | ●●●○●●●●○○○(7/12) | |
Gangadhar, V.2011 | Cross-sectional | India(Indian) | P | 25/25 | 18-60 | Not mentioned | Not mentioned | Mixed | Leptin | ●●○○●○●○○○○(4/12) | |
Gundala, R.2014 | Cross-sectional | India(Indian) | CP | 30/30;30/30 | 44.9/48.3;48.9/47.8 | 27.4/21.7;30.8/21.6 | Free/AMI | Mixed | Leptin | ●●●○●●●○○○○(6/12) | |
Karthikeyan, B. V 2007 | Cross-sectional | India(Indian) | CP | 14/14 | 30–39 matiched | Normal BMI | Not mentioned | Mixed | Leptin | ●●○●●●●●○○○(7/12) | |
Mendoza-Azpur 2015 | Cross-sectional | Peru (Peruvian) | CP | 19/29;24/21 | 41.4/42.5;47.2/26.9 | Normal BMI; Obesity | Free | Free | Leptin/Adiponectin | ●●●○●●●●○○○(7/12) | |
Nagano, Y 2011 | Cross-sectional | Japan(Asian) | CP | 62/89 | 55.7/50.7 | 24.4/24.2 | Not mentioned | Mixed | Adiponectin | ●●○●●○●●○○○(6/12) | |
Purwar, P.A 2015 | Cross-sectional | India(Indian) | CP | 44/40 | 49.3/49.9 | 20.62/20.69 | Free | Free | Leptin | ●●●○●●●●○○○(7/12) | |
Saito, T 2008 | Cross-sectional | Japan(Asian) | CP | 34/42 | 55.2/55.1 | 23.3/21.9 | Not mentioned | Mixed | Adiponectin | ●●●●●●●○○○○(7/12) | |
Sete, M. R. | Cross-sectional | Brazil (Brazilian) | CP | 15/15 | 45.7/32.1 | 28.8/Not mentioned | Free | Free | Leptin/Adiponectin | ●●○○●●●○○○○(5/12) | |
Shi, D 2015 | Cross-sectional | China (Asian) | AP | 90/44 | 26.2/25.6 | 21.9/21.1 | Free | Mixed | Leptin | ●●●○●●●●○○○(7/12) | |
Thanakun, S.2014 | Cross-sectional | Thai (Asian) | CP | 58/67 | 50.0/46.0 | 24.9/23.5 | Mixed | Mixed | Leptin/Adiponectin | ●●●○●●●●○○○(7/12) | |
Zimmermann, G. S2013 | Cross-sectional | Brazil (Brazilian) | CP | 20/20;20/18 | 47.8/42.9;51.2/43.2 | 23.0/23.4;33.2/33.9 | Free | Free | Leptin/Adiponectin | ●●●○●●●●○○○(7/12) | |
Authors and years | Study design | Country (Ethnicity) | Group size | Age(NG/OBG) | BMI(NG/OBG | Systemic disease | Smoking | Adipokine | Periodontal treatment | Quality assessment | Time interval |
Altay, U. A 2013 | Double-arm clinical trial | Turkey (Caucasion) | 24/22 | 42.5/45.6 | 26.3/32.2 | Free | Mixed | Leptin | SRP | ●◐●●◐●◐●(13/16) | 3 month |
Behle, Jan H 2009 | Single-arm clinical trial | USA (mixed) | 28 | 43.3 | Not mentioned | Free | Free | Adiponectin | SRP + Periodontal surgery | ●◐●●◐◐●◐ (12/16) | 1 month |
Bharti, P 2013 | Controlled clinical trial | Japan(Asian) | 21 | 60.2 | 24.2 | T2DM | Free | Adiponectin | SRP + Topical antibiotics | ●◐●●◐●◐◐(12/16) | 2 month |
Duzagac, E 2015 | Double-arm clinical trial | Turkey (Caucasion) | 15/15 | 41.06/40.66 | 22.14/36.26 | Free | Free | Adiponectin | SRP | ●◐●●◐●●◐ (13/16) | 3 month |
Goncalves, T. E A 2015 | Double-arm clinical trial | Brazil (mixed) | 24/24 | 48.4/48.8 | 24.4/33.2 | Free | Free | Leptin/Adiponectin | SRP | ●●●●◐●◐●(14/16) | 3 month |
Goncalves, T. E B 2015 | Double-arm clinical trial | Brazil (mixed) | 20/20 | 48.5/50.0 | 23.4/36.1 | Free | Free | Leptin/Adiponectin | SRP | ●●●●◐●●●(15/16) | 3 month |
Purwar, P.B 2015 | Single-arm clinical trial | India(Indian) | 22 | 35-60 | 20.45 | Free | Free | Leptin | SRP | ●◐●●◐●◐●(13/16) | 3 month |
Shimada, Y.2010 | Single-arm clinical trial | Japan(Asian) | 33 | 55.1 | 22.5 | Free | Mixed | Leptin | SRP | ●◐●●◐◐●◐(12/16) | 1 month |
Sun, W. L2011 | Randomized controlled clinical trial | China(Asian) | 82 | 55.13 | 23.71 | T2DM | Free | Adiponectin | SRP + Periodontal surgery | ●◐●●◐●●◐ (13/16) | 3 month |
Overall and subgroup analyses
Overall and subgroup analyses | No. of observations | Association | Heterogeneity | Model | Publication bias (P) | ||
---|---|---|---|---|---|---|---|
SMD (95% CI) |
p value |
I
2 (%) |
P value | ||||
L1 | 20 | 0.799 (0.308–1.289) | 0.000 | 92.2 | 0.000 | Random | 0.289 |
BMI <30 | 14 | 0.987 (0.317–1.657) | 0.000 | 93.9 | 0.000 | Random | |
BMI ≥30 | 3 | 0.024 (−0.790–0.839) | 0.953 | 81.3 | 0.005 | Random | |
CP | 13 | 0.708 (0.142–1.273) | 0.014 | 91.6 | 0.000 | Random | |
AP | 5 | 1.046 (−0.366–2.458) | 0.147 | 94.8 | 0.000 | Random | |
Systemic disease (free) | 15 | 0.822 (0.225–1.418) | 0.007 | 92.1 | 0.000 | Random | |
Systemic disease (mixed) | 5 | 0.721 (−0.135–1.576) | 0.099 | 91.6 | 0.000 | Random | |
Smoking (free) | 9 | 0.656 (−0.076–1.389) | 0.079 | 90.6 | 0.000 | Random | |
Smoking (mixed) | 11 | 0.913 (0.223–1.602) | 0.009 | 93.6 | 0.000 | Random | |
A1 | 14 | −0.323 (−0.525 to −0.121) | 0.002 | 50.2 | 0.016 | Random | 0.203 |
BMI <30 | 10 | −0.243(−0.390 to −0.096) | 0.001 | 48.8 | 0.040 | Fixed | |
BMI ≥30 | 3 | −0.326 (−0.677–0.024) | 0.068 | 33.9 | 0.220 | Fixed | |
CP | 12 | −0.317 (−0.540 to −0.095) | 0.005 | 56.3 | 0.009 | Random | |
AP | 1 | NA | |||||
Systemic disease (free) | 9 | −0.457 (−0.809 to −0.104) | 0.011 | 60.2 | 0.010 | Random | |
Systemic disease (mixed) | 5 | −0.206 (−0.374 to −0.038) | 0.016 | 0.0 | 0.427 | Fixed | |
Smoking (free) | 7 | −0.480 (−0.923 to −0.037) | 0.034 | 69.2 | 0.003 | Random | |
Smoking (mixed) | 7 | −0.227 (−0.387 to −0.068) | 0.005 | 0.0 | 0.530 | Fixed | |
L2 | 9 | −0.412 (−0.864–0.040) | 0.074 | 79.7 | 0.000 | Random | 0.065 |
BMI <30 | 6 | −0.541 (−1.213–0.130) | 0.114 | 86.4 | 0.000 | Random | |
BMI ≥30 | 3 | −0.201 (−0.562–0.159) | 0.273 | 0.0 | 0.393 | Fixed | |
Smoking (free) | 7 | −0.439 (−1.052–0.174) | 0.160 | 84.4 | 0.000 | Random | |
Smoking (Mixed) | 2 | −0.336 (−0.707–0.034) | 0.075 | 0.0 | 0.326 | Fixed | |
A2 | 9 | 0.298 (0.117–0.479) | 0.001 | 33.2 | 0.157 | Fixed | 0.042 |
BMI <30 | 5 | 0.384 (0.161–0.607) | 0.001 | 54.2 | 0.068 | Fixed | |
BMI ≥30 | 3 | 0.171 (−0.212–0.554) | 0.382 | 0.0 | 0.479 | Fixed | |
SRP | 6 | 0.117 (−0.150–0.384) | 0.389 | 0.0 | 0.634 | Fixed | |
SRP + peridontal surgery | 2 | 0.409 (−0.193–1.011) | 0.183 | 74.6 | 0.047 | Random | |
SRP + topical antibiotics | 1 | NA | |||||
Systemic disease (free) | 7 | 0.106 (−0.132–0.344) | 0.382 | 0.0 | 0.749 | Fixed | |
Systemic disease (T2DM) | 2 | 0.466 (−0.066–0.997) | 0.086 | 60.9 | 0.110 | Random |